Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma Interventions: Drug: Lenvatinib Sponsors: Asan Medical Center; Eisai Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Avastin | Cancer & Oncology | Carcinoma | Hepatocellular Carcinoma | Liver Cancer | Research